| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11886-018-1013-8 |
| P698 | PubMed publication ID | 29992480 |
| P2093 | author name string | Michael Miller | |
| Tapati Stalam | |||
| Matthew C Evans | |||
| P2860 | cites work | Hypertriglyceridemia: its etiology, effects and treatment | Q24672914 |
| Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico | Q28143207 | ||
| Intake of fish and omega-3 fatty acids and risk of stroke in women | Q28175802 | ||
| MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial | Q28214393 | ||
| Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association | Q28235865 | ||
| Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) | Q29547825 | ||
| The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators | Q29547887 | ||
| Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study | Q29617822 | ||
| Intensive versus moderate lipid lowering with statins after acute coronary syndromes | Q29619716 | ||
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 | ||
| Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels | Q29620696 | ||
| Effects of combination lipid therapy in type 2 diabetes mellitus | Q33889260 | ||
| Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemia | Q34042886 | ||
| Treatment options for the management of hypertriglyceridemia: strategies based on the best-available evidence | Q34301772 | ||
| Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction | Q34318279 | ||
| National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary | Q34439436 | ||
| Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes | Q34479098 | ||
| High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial | Q34562602 | ||
| Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis | Q34578231 | ||
| Effects of extended-release niacin with laropiprant in high-risk patients | Q35205560 | ||
| (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? | Q35753222 | ||
| The ACCORD-Lipid study: implications for treatment of dyslipidemia in Type 2 diabetes mellitus | Q35871965 | ||
| Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges | Q36968971 | ||
| Overview of omega-3 Fatty Acid therapies | Q37419411 | ||
| Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association | Q38124498 | ||
| Triglycerides and cardiovascular disease | Q38240749 | ||
| HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial | Q38467184 | ||
| OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction | Q38497919 | ||
| 30-year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II, III, and 1999-2006. | Q39835747 | ||
| Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women | Q40192779 | ||
| Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease | Q40287836 | ||
| Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study). | Q42713425 | ||
| n-3 fatty acids and cardiovascular events after myocardial infarction | Q42867424 | ||
| Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. | Q43826699 | ||
| Intensive lipid lowering with atorvastatin in patients with stable coronary disease | Q45310626 | ||
| Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial | Q46750170 | ||
| Effects of icosapent ethyl on lipoprotein particle concentration and size in statin-treated patients with persistent high triglycerides (the ANCHOR Study). | Q47381173 | ||
| n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. | Q51355736 | ||
| Triglycerides and the Risk of Coronary Heart Disease | Q57267183 | ||
| Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women | Q61162458 | ||
| 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults | Q61985181 | ||
| Lipoprotein physiology | Q77452731 | ||
| Common genetic variants contribute to primary hypertriglyceridemia without differences between familial combined hyperlipidemia and isolated hypertriglyceridemia | Q85226885 | ||
| Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study | Q87117212 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypertriglyceridemia | Q1467339 |
| P304 | page(s) | 71 | |
| P577 | publication date | 2018-07-10 | |
| P1433 | published in | Current cardiology reports | Q26842345 |
| P1476 | title | Cardiovascular Risk Assessment in Patients with Hypertriglyceridemia | |
| P478 | volume | 20 |
Search more.